{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T09:48:08Z","timestamp":1768470488062,"version":"3.49.0"},"reference-count":124,"publisher":"Bentham Science Publishers Ltd.","issue":"2","funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81503462"],"award-info":[{"award-number":["81503462"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["eurekaselect.com"],"crossmark-restriction":true},"short-container-title":["CDT"],"published-print":{"date-parts":[[2023,2]]},"abstract":"<jats:sec>\n<jats:title>Abstract:<\/jats:title>\n<jats:p>Alzheimer's disease (AD) has become the fourth leading cause of death in the world. Due to its complex pathogenesis, there is still a lack of effective drug treatments. Studies have found that the metal dyshomeostasis is closely related to other pathogeneses of AD such as oxidative stress, \u03b2-amyloid protein deposits, etc. Therefore, it becomes an important target to find the appropriate metal chelating agents to regulate the metal homeostasis. At the same time, because of the complex pathogenesis, single target drugs cannot achieve good effects. Therefore, current studies are mainly focused on exploring multi-target therapy for AD. In this work, the multi-target studies based on metal chelators and other targets with synergistic anti-AD activities were reviewed. The structural characteristics of different chelating agents were summarized and the structure-activity relationship was analyzed, which provided some valuable clues for the subsequent development of anti-AD multi-target drugs based on metal chelating agents.<\/jats:p>\n<\/jats:sec>","DOI":"10.2174\/1389450123666220926143920","type":"journal-article","created":{"date-parts":[[2022,9,27]],"date-time":"2022-09-27T11:59:34Z","timestamp":1664279974000},"page":"131-150","update-policy":"https:\/\/doi.org\/10.2174\/bsp_crossmark_policy","source":"Crossref","is-referenced-by-count":4,"title":["Study on Multi-Target Synergistic Treatment of Alzheimer\u2019s Disease\nBased on Metal Chelators"],"prefix":"10.2174","volume":"24","author":[{"given":"Rui","family":"Shen","sequence":"first","affiliation":[{"name":"School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaodi","family":"Kou","sequence":"first","affiliation":[{"name":"School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aihong","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Wu","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhong","family":"Chen","sequence":"additional","affiliation":[{"name":"School of Chinese Materia Medica, Tianjin University of Traditional Chinese Medicine, Tianjin, 301617, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"965","reference":[{"key":"ref=1","doi-asserted-by":"publisher","first-page":"983","DOI":"10.3233\/JAD-190302","volume":"70","author":"Nance C.","year":"2019","unstructured":"Nance C.; Ritter A.; Miller J.B.; Lapin B.; Banks S.J.; The pathology of rapid cognitive decline in clinically diagnosed Alzheimer\u2019s disease. J Alzheimers Dis 2019,70(4),983-993","journal-title":"J Alzheimers Dis"},{"key":"ref=2","doi-asserted-by":"publisher","first-page":"3141","DOI":"10.2174\/0929867323666161213101126","volume":"25","author":"dos Santos P.L.C.","year":"2018","unstructured":"dos Santos P.L.C.; Ozela P.F.; de Fatima B.B.M.; Alzheimer\u2019s disease: A review from the pathophysiology to diagnosis, new perspectives for pharmacological treatment. Curr Med Chem 2018,25(26),3141-3159","journal-title":"Curr Med Chem"},{"key":"ref=3","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/alz.12328","volume":"17","year":"2021","unstructured":"Alzheimer\u2019s Association Report. 2021 Alzheimer\u2019s disease facts and figures. Alzheimers Dement 2021,17(3),327-406","journal-title":"Alzheimers Dement"},{"key":"ref=4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.1016\/j.jalz.2017.12.006","volume":"14","author":"Jia J.","year":"2018","unstructured":"Jia J.; Wei C.; Chen S.; The cost of Alzheimer\u2019s disease in China and re\u2010estimation of costs worldwide. Alzheimers Dement 2018,14(4),483-491","journal-title":"Alzheimers Dement"},{"key":"ref=5","doi-asserted-by":"publisher","first-page":"11398","DOI":"10.1038\/ncomms11398","volume":"7","author":"Matthews F.E.","year":"2016","unstructured":"Matthews F.E.; Stephan B.C.M.; Robinson L.; A two decade dementia incidence comparison from the cognitive function and ageing studies I and II. Nat Commun 2016,7(1),11398","journal-title":"Nat Commun"},{"key":"ref=6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.2174\/1389450121999201209201004","volume":"22","author":"Iqubal A.","year":"2021","unstructured":"Iqubal A.; Rahman S.O.; Ahmed M.; Current quest in natural bioactive compounds for Alzheimer\u2019s disease: Multi-targeted-designed-ligand based approach with preclinical and clinical based evidence. Curr Drug Targets 2021,22(6),685-720","journal-title":"Curr Drug Targets"},{"key":"ref=7","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1038\/nrd2896","volume":"9","author":"Citron M.","year":"2010","unstructured":"Citron M.; Alzheimer\u2019s disease: Strategies for disease modification. Nat Rev Drug Discov 2010,9(5),387-398","journal-title":"Nat Rev Drug Discov"},{"key":"ref=8","doi-asserted-by":"publisher","first-page":"505","DOI":"10.2174\/1389450121999200819144544","volume":"22","author":"Pirolla N.F.F.","year":"2021","unstructured":"Pirolla N.F.F.; Batista V.S.; Dias Viegas F.P.; Alzheimer\u2019s disease: Related targets, synthesis of available drugs, bioactive compounds under development and promising results obtained from multi-target approaches. Curr Drug Targets 2021,22(5),505-538","journal-title":"Curr Drug Targets"},{"key":"ref=9","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.ejmech.2015.03.040","volume":"95","author":"Xie S.S.","year":"2015","unstructured":"Xie S.S.; Wang X.; Jiang N.; Multi-target tacrine-coumarin hybrids: Cholinesterase and monoamine oxidase B inhibition properties against Alzheimer\u2019s disease. Eur J Med Chem 2015,95,153-165","journal-title":"Eur J Med Chem"},{"key":"ref=10","doi-asserted-by":"publisher","first-page":"6018","DOI":"10.1021\/acs.jmedchem.5b00624","volume":"58","author":"Sola I.","year":"2015","unstructured":"Sola I.; Aso E.; Frattini D.; Novel levetiracetam derivatives that are effective against the Alzheimer-like phenotype in mice: Synthesis, in vitro, ex vivo and in vivo efficacy studies. J Med Chem 2015,58(15),6018-6032","journal-title":"J Med Chem"},{"key":"ref=11","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.3233\/JAD-170662","volume":"62","author":"Adlard P.A.","year":"2018","unstructured":"Adlard P.A.; Bush A.I.; Metals and Alzheimer\u2019s disease: How far have we come in the clinic? J Alzheimers Dis 2018,62(3),1369-1379","journal-title":"J Alzheimers Dis"},{"key":"ref=12","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/S0022-510X(98)00092-6","volume":"158","author":"Lovell M.A.","year":"1998","unstructured":"Lovell M.A.; Robertson J.D.; Teesdale W.J.; Campbell J.L.; Markesbery W.R.; Copper, iron and zinc in Alzheimer\u2019s disease senile plaques. J Neurol Sci 1998,158(1),47-52","journal-title":"J Neurol Sci"},{"key":"ref=13","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1007\/s10534-014-9728-5","volume":"27","author":"Gonz&#xE1;lez-Dom&#xED;nguez R.","year":"2014","unstructured":"Gonz&#xE1;lez-Dom&#xED;nguez R.; Garc&#xED;a-Barrera T.; G&#xF3;mez-Ariza J.L.; Homeostasis of metals in the progression of Alzheimer\u2019s disease. Biometals 2014,27(3),539-549","journal-title":"Biometals"},{"key":"ref=14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.2478\/v10007-011-0006-6","volume":"61","author":"Budimir A.","year":"2011","unstructured":"Budimir A.; Metal ions, Alzheimer\u2019s disease and chelation therapy. Acta Pharm 2011,61(1),1-14","journal-title":"Acta Pharm"},{"key":"ref=15","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1002\/psc.2789","volume":"21","author":"Qiu T","year":"2015","unstructured":"Qiu T; Liu Q; Chen YX; Zhao YF; Li YM. A; &#x3B2; 42 and A &#x3B2; 40: Similarities and differences J Pept Sci 2015,21(7),522-529","journal-title":"J Pept Sci"},{"key":"ref=16","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1038\/nrn2168","volume":"8","author":"LaFerla F.M.","year":"2007","unstructured":"LaFerla F.M.; Green K.N.; Oddo S.; Intracellular amyloid-&#x3B2; in Alzheimer\u2019s disease. Nat Rev Neurosci 2007,8(7),499-509","journal-title":"Nat Rev Neurosci"},{"key":"ref=17","doi-asserted-by":"publisher","first-page":"1183","DOI":"10.1038\/s41593-020-0687-6","volume":"23","author":"Busche M.A.","year":"2020","unstructured":"Busche M.A.; Hyman B.T.; Synergy between amyloid-&#x3B2; and tau in Alzheimer\u2019s disease. Nat Neurosci 2020,23(10),1183-1193","journal-title":"Nat Neurosci"},{"key":"ref=18","doi-asserted-by":"publisher","first-page":"186","DOI":"10.1039\/B912601E","volume":"2","author":"Brown D.R.","year":"2010","unstructured":"Brown D.R.; Metalloproteins and neuronal death. Metallomics 2010,2(3),186-194","journal-title":"Metallomics"},{"key":"ref=19","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1515\/revneuro-2019-0052","volume":"31","author":"Isaev N.K.","year":"2020","unstructured":"Isaev N.K.; Stelmashook E.V.; Genrikhs E.E.; Role of zinc and copper ions in the pathogenetic mechanisms of traumatic brain injury and Alzheimer\u2019s disease. Rev Neurosci 2020,31(3),233-243","journal-title":"Rev Neurosci"},{"key":"ref=20","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.neuro.2020.07.003","volume":"80","author":"Xie Z.","year":"2020","unstructured":"Xie Z.; Wu H.; Zhao J.; Multifunctional roles of zinc in Alzheimer\u2019s disease. Neurotoxicology 2020,80,112-123","journal-title":"Neurotoxicology"},{"key":"ref=21","doi-asserted-by":"publisher","first-page":"3622","DOI":"10.1111\/bph.14567","volume":"176","author":"Nikseresht S.","year":"2019","unstructured":"Nikseresht S.; Bush A.I.; Ayton S.; Treating Alzheimer\u2019s disease by targeting iron. Br J Pharmacol 2019,176(18),3622-3635","journal-title":"Br J Pharmacol"},{"key":"ref=22","doi-asserted-by":"publisher","first-page":"1332","DOI":"10.1021\/acs.accounts.5b00119","volume":"48","author":"Robert A.","year":"2015","unstructured":"Robert A.; Liu Y.; Nguyen M.; Meunier B.; Regulation of copper and iron homeostasis by metal chelators: A possible chemotherapy for Alzheimer\u2019s disease. Acc Chem Res 2015,48(5),1332-1339","journal-title":"Acc Chem Res"},{"key":"ref=23","doi-asserted-by":"publisher","first-page":"625","DOI":"10.1111\/j.1742-4658.2007.06238.x","volume":"275","author":"Inestrosa N.C.","year":"2008","unstructured":"Inestrosa N.C.; Dinamarca M.C.; Alvarez A.; Amyloid-cholinesterase interactions. FEBS J 2008,275(4),625-632","journal-title":"FEBS J"},{"key":"ref=24","doi-asserted-by":"publisher","first-page":"438","DOI":"10.1111\/j.1471-4159.2006.04079.x","volume":"99","author":"Ghribi O.","year":"2006","unstructured":"Ghribi O.; Golovko M.Y.; Larsen B.; Schrag M.; Murphy E.J.; Deposition of iron and? -amyloid plaques is associated with cortical cellular damage in rabbits fed with long-term cholesterol-enriched diets. J Neurochem 2006,99(2),438-449","journal-title":"J Neurochem"},{"key":"ref=25","doi-asserted-by":"publisher","first-page":"6695","DOI":"10.1021\/acs.inorgchem.7b00782","volume":"56","author":"Ji Y.","year":"2017","unstructured":"Ji Y.; Lee H.J.; Kim M.; Strategic design of 2,2\u2032-bipyridine derivatives to modulate metal-amyloid-&#x3B2; aggregation. Inorg Chem 2017,56(11),6695-6705","journal-title":"Inorg Chem"},{"key":"ref=26","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1016\/j.ejmech.2017.09.057","volume":"141","author":"Iraji A.","year":"2017","unstructured":"Iraji A.; Firuzi O.; Khoshneviszadeh M.; Multifunctional iminochromene-2H-carboxamide derivatives containing different aminomethylene triazole with BACE1 inhibitory, neuroprotective and metal chelating properties targeting Alzheimer\u2019s disease. Eur J Med Chem 2017,141,690-702","journal-title":"Eur J Med Chem"},{"key":"ref=27","doi-asserted-by":"publisher","first-page":"1642","DOI":"10.1016\/j.bcp.2005.09.003","volume":"70","author":"Zheng H.","year":"2005","unstructured":"Zheng H.; Youdim M.B.H.; Weiner L.M.; Fridkin M.; Novel potential neuroprotective agents with both iron chelating and amino acid-based derivatives targeting central nervous system neurons. Biochem Pharmacol 2005,70(11),1642-1652","journal-title":"Biochem Pharmacol"},{"key":"ref=28","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.ejmech.2019.04.060","volume":"174","author":"Sestito S.","year":"2019","unstructured":"Sestito S.; Wang S.; Chen Q.; Multi-targeted chei-copper chelating molecules as neuroprotective agents. Eur J Med Chem 2019,174,216-225","journal-title":"Eur J Med Chem"},{"key":"ref=29","doi-asserted-by":"publisher","first-page":"e2000442","DOI":"10.1002\/cbdv.202000442","volume":"17","author":"Yang A.","year":"2020","unstructured":"Yang A.; Yu Q.; Ju H.; Song L.; Kou X.; Shen R.; Design, synthesis and biological evaluation of xanthone derivatives for possible treatment of Alzheimer\u2019s disease based on multi-target strategy. Chem Biodivers 2020,17(10),e2000442","journal-title":"Chem Biodivers"},{"key":"ref=30","doi-asserted-by":"publisher","first-page":"104146","DOI":"10.1016\/j.bioorg.2020.104146","volume":"103","author":"Haghighijoo Z.","year":"2020","unstructured":"Haghighijoo Z.; Akrami S.; Saeedi M.; N-Cyclohexylimidazo[1,2-a]pyridine derivatives as multi-target-directed ligands for treatment of Alzheimer\u2019s disease. Bioorg Chem 2020,103,104146","journal-title":"Bioorg Chem"},{"key":"ref=31","doi-asserted-by":"publisher","first-page":"205","DOI":"10.3389\/fnins.2016.00205","volume":"10","author":"Unzeta M.","year":"2016","unstructured":"Unzeta M.; Esteban G.; Bolea I.; Multi-target directed donepezil-like ligands for Alzheimer\u2019s disease. Front Neurosci 2016,10,205","journal-title":"Front Neurosci"},{"key":"ref=32","doi-asserted-by":"publisher","first-page":"668","DOI":"10.1016\/j.bmc.2015.01.005","volume":"23","author":"Sang Z.","year":"2015","unstructured":"Sang Z.; Li Y.; Qiang X.; Multifunctional scutellarin\u2013rivastigmine hybrids with cholinergic, antioxidant, biometal chelating and neuroprotective properties for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem 2015,23(4),668-680","journal-title":"Bioorg Med Chem"},{"key":"ref=33","doi-asserted-by":"publisher","first-page":"5046","DOI":"10.1016\/j.bmcl.2017.09.057","volume":"27","author":"Sang Z.","year":"2017","unstructured":"Sang Z.; Wang K.; Wang H.; Design, synthesis and biological evaluation of 2-acetyl-5- O -(amino-alkyl)phenol derivatives as multifunctional agents for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem Lett 2017,27(22),5046-5052","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=34","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/j.bioorg.2018.10.065","volume":"83","author":"Rastegari A.","year":"2019","unstructured":"Rastegari A.; Nadri H.; Mahdavi M.; Design, synthesis and anti-Alzheimer\u2019s activity of novel 1,2,3-triazole-chromenone carboxamide derivatives. Bioorg Chem 2019,83,391-401","journal-title":"Bioorg Chem"},{"key":"ref=35","doi-asserted-by":"publisher","first-page":"2000258","DOI":"10.1002\/ardp.202000258","volume":"354","author":"Saeedi M.","year":"2021","unstructured":"Saeedi M.; Felegari P.; Iraji A.; Novel N \u2010benzylpiperidine derivatives of 5\u2010arylisoxazole\u20103\u2010carboxamides as anti\u2010Alzheimer\u2019s agents. Arch Pharm 2021,354(3),2000258","journal-title":"Arch Pharm"},{"key":"ref=36","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ejmech.2013.03.051","volume":"64","author":"Xie S.S.","year":"2013","unstructured":"Xie S.S.; Wang X.B.; Li J.Y.; Yang L.; Kong L.Y.; Design, synthesis and evaluation of novel tacrine\u2013coumarin hybrids as multifunctional cholinesterase inhibitors against Alzheimer\u2019s disease. Eur J Med Chem 2013,64,540-553","journal-title":"Eur J Med Chem"},{"key":"ref=37","doi-asserted-by":"publisher","first-page":"103499","DOI":"10.1016\/j.bioorg.2019.103499","volume":"95","author":"El-Sayed N.F.","year":"2020","unstructured":"El-Sayed N.F.; El-Hussieny M.; Ewies E.F.; Fouad M.A.; Boulos L.S.; New phosphazine and phosphazide derivatives as multifunctional ligands targeting acetylcholinesterase and &#x3B2;-Amyloid aggregation for treatment of Alzheimer\u2019s disease. Bioorg Chem 2020,95,103499","journal-title":"Bioorg Chem"},{"key":"ref=38","doi-asserted-by":"publisher","first-page":"103006","DOI":"10.1016\/j.bioorg.2019.103006","volume":"89","author":"Riazimontazer E.","year":"2019","unstructured":"Riazimontazer E.; Sadeghpour H.; Nadri H.; Design, synthesis and biological activity of novel tacrine-isatin Schiff base hybrid derivatives. Bioorg Chem 2019,89,103006","journal-title":"Bioorg Chem"},{"key":"ref=39","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1080\/14756366.2016.1186019","volume":"31","author":"Koca M.","year":"2016","unstructured":"Koca M.; Yerdelen K.O.; Anil B.; Design, synthesis and biological activity of 1H-indene-2-carboxamides as multi-targeted anti-Alzheimer agents. J Enzyme Inhib Med Chem 2016,31(S2),13-23","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=40","doi-asserted-by":"publisher","first-page":"776","DOI":"10.1080\/14756366.2016.1256883","volume":"32","author":"Lan J.S.","year":"2017","unstructured":"Lan J.S.; Hou J.W.; Liu Y.; Design, synthesis and evaluation of novel cinnamic acid derivatives bearing N -benzyl pyridinium moiety as multifunctional cholinesterase inhibitors for Alzheimer\u2019s disease. J Enzyme Inhib Med Chem 2017,32(1),776-788","journal-title":"J Enzyme Inhib Med Chem"},{"key":"ref=41","doi-asserted-by":"publisher","first-page":"64","DOI":"10.1186\/s13065-020-00715-0","volume":"14","author":"Karimi Askarani H.","year":"2020","unstructured":"Karimi Askarani H.; Iraji A.; Rastegari A.; Design and synthesis of multi-target directed 1,2,3-triazole-dimethylaminoacryloyl-chromenone derivatives with potential use in Alzheimer\u2019s disease. BMC Chem 2020,14(1),64","journal-title":"BMC Chem"},{"key":"ref=42","doi-asserted-by":"publisher","first-page":"127477","DOI":"10.1016\/j.bmcl.2020.127477","volume":"30","author":"Singh A.","year":"2020","unstructured":"Singh A.; Sharma S.; Arora S.; New coumarin-benzotriazole based hybrid molecules as inhibitors of acetylcholinesterase and amyloid aggregation. Bioorg Med Chem Lett 2020,30(20),127477","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=43","doi-asserted-by":"publisher","first-page":"2","DOI":"10.1016\/j.ejmech.2019.04.038","volume":"175","author":"Umar T.","year":"2019","unstructured":"Umar T.; Shalini S.; Raza M.K.; A multifunctional therapeutic approach: Synthesis, biological evaluation, crystal structure and molecular docking of diversified 1H-pyrazolo[3,4-b]pyridine derivatives against Alzheimer\u2019s disease. Eur J Med Chem 2019,175,2-19","journal-title":"Eur J Med Chem"},{"key":"ref=44","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1016\/j.bioorg.2019.03.058","volume":"87","author":"Kaur A.","year":"2019","unstructured":"Kaur A.; Mann S.; Kaur A.; Multi-target-directed triazole derivatives as promising agents for the treatment of Alzheimer\u2019s disease. Bioorg Chem 2019,87,572-584","journal-title":"Bioorg Chem"},{"key":"ref=45","doi-asserted-by":"publisher","first-page":"322","DOI":"10.1016\/j.jinorgbio.2012.05.016","volume":"117","author":"No&#xEB;l S.","year":"2012","unstructured":"No&#xEB;l S.; Perez F.; Pedersen J.T.; A new water-soluble Cu(II) chelator that retrieves Cu from Cu(amyloid-&#x3B2;) species, stops associated ROS production and prevents Cu(II)\u2010induced A&#x3B2; aggregation. J Inorg Biochem 2012,117,322-325","journal-title":"J Inorg Biochem"},{"key":"ref=46","doi-asserted-by":"publisher","first-page":"9146","DOI":"10.1021\/jm3003813","volume":"55","author":"Geng J.","year":"2012","unstructured":"Geng J.; Li M.; Wu L.; Ren J.; Qu X.; Liberation of copper from amyloid plaques: Making a risk factor useful for Alzheimer\u2019s disease treatment. J Med Chem 2012,55(21),9146-9155","journal-title":"J Med Chem"},{"key":"ref=47","doi-asserted-by":"publisher","first-page":"1824","DOI":"10.1021\/acs.chemrestox.9b00168","volume":"32","author":"Kaur A.","year":"2019","unstructured":"Kaur A.; Narang S.S.; Kaur A.; Multifunctional mono-triazole derivatives inhibit A&#x3B2;42 aggregation and Cu2+-mediated A&#x3B2;42 aggregation and protect against A&#x3B2;42-induced cytotoxicity. Chem Res Toxicol 2019,32(9),1824-1839","journal-title":"Chem Res Toxicol"},{"key":"ref=48","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.ejmech.2014.10.004","volume":"87","author":"Jiang N.","year":"2014","unstructured":"Jiang N.; Li S.Y.; Xie S.S.; Design, synthesis and evaluation of multifunctional salphen derivatives for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 2014,87,540-551","journal-title":"Eur J Med Chem"},{"key":"ref=49","doi-asserted-by":"publisher","first-page":"3815","DOI":"10.1016\/j.bmc.2017.05.027","volume":"25","author":"Li F.","year":"2017","unstructured":"Li F.; Wu J.J.; Wang J.; Synthesis and pharmacological evaluation of novel chromone derivatives as balanced multifunctional agents against Alzheimer\u2019s disease. Bioorg Med Chem 2017,25(14),3815-3826","journal-title":"Bioorg Med Chem"},{"key":"ref=50","doi-asserted-by":"publisher","first-page":"8483","DOI":"10.1021\/jm300978h","volume":"55","author":"Huang L.","year":"2012","unstructured":"Huang L.; Lu C.; Sun Y.; Multitarget-directed benzylideneindanone derivatives: Anti-&#x3B2;-amyloid (A&#x3B2;) aggregation, antioxidant, metal chelation, and monoamine oxidase B (MAO-B) inhibition properties against Alzheimer\u2019s disease. J Med Chem 2012,55(19),8483-8492","journal-title":"J Med Chem"},{"key":"ref=51","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1155\/2013\/567128","volume":"2013","author":"Singh S.K.","year":"2013","unstructured":"Singh S.K.; Sinha P.; Mishra L.; Srikrishna S.; Neuroprotective role of a novel copper chelator against A&#x3B2;42 induced neurotoxicity. Int J Alzheimers Dis 2013,2013,1-9","journal-title":"Int J Alzheimers Dis"},{"key":"ref=52","doi-asserted-by":"publisher","first-page":"43","DOI":"10.1016\/j.neuron.2008.06.018","volume":"59","author":"Adlard P.A.","year":"2008","unstructured":"Adlard P.A.; Cherny R.A.; Finkelstein D.I.; Rapid restoration of cognition in Alzheimer\u2019s transgenic mice with 8-hydroxy quinoline analogs is associated with decreased interstitial Abeta. Neuron 2008,59(1),43-55","journal-title":"Neuron"},{"key":"ref=53","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3233\/JAD-2010-1390","volume":"20","author":"Faux N.G.","year":"2010","unstructured":"Faux N.G.; Ritchie C.W.; Gunn A.; PBT2 rapidly improves cognition in Alzheimer\u2019s Disease: Additional phase II analyses. J Alzheimers Dis 2010,20(2),509-516","journal-title":"J Alzheimers Dis"},{"key":"ref=54","doi-asserted-by":"publisher","first-page":"3191","DOI":"10.1016\/j.bmc.2018.04.043","volume":"26","author":"Yang X.","year":"2018","unstructured":"Yang X.; Cai P.; Liu Q.; Novel 8-hydroxyquinoline derivatives targeting &#x3B2;-amyloid aggregation, metal chelation and oxidative stress against Alzheimer\u2019s disease. Bioorg Med Chem 2018,26(12),3191-3201","journal-title":"Bioorg Med Chem"},{"key":"ref=55","doi-asserted-by":"publisher","first-page":"6771","DOI":"10.1002\/chem.201402143","volume":"20","author":"Nguyen M.","year":"2014","unstructured":"Nguyen M.; Robert A.; Sournia-Saquet A.; Vendier L.; Meunier B.; Characterization of new specific copper chelators as potential drugs for the treatment of Alzheimer\u2019s disease. Chemistry 2014,20(22),6771-6785","journal-title":"Chemistry"},{"key":"ref=56","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1039\/C5IB00064E","volume":"7","author":"Yang Y.","year":"2015","unstructured":"Yang Y.; Chen T.; Zhu S.; Two macrocyclic polyamines as modulators of metal-mediated A&#x3B2; 40 aggregation. Integr Biol 2015,7(6),655-662","journal-title":"Integr Biol"},{"key":"ref=57","doi-asserted-by":"publisher","first-page":"2072","DOI":"10.1039\/C4MT00161C","volume":"6","author":"Gonzalez P.","year":"2014","unstructured":"Gonzalez P.; da Costa V.C.P.; Hyde K.; Bimodal-hybrid heterocyclic amine targeting oxidative pathways and copper mis-regulation in Alzheimer\u2019s disease. Metallomics 2014,6(11),2072-2082","journal-title":"Metallomics"},{"key":"ref=58","doi-asserted-by":"publisher","first-page":"259","DOI":"10.1039\/B712377A","volume":"14","author":"Jiang W.","year":"2008","unstructured":"Jiang W.; Fu Q.; Fan H.; Wang W.; An NBD fluorophore-based sensitive and selective fluorescent probe for zinc ion. Chem Commun 2008,14(2),259-261","journal-title":"Chem Commun"},{"key":"ref=59","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.fct.2018.03.035","volume":"119","author":"Chen T.","year":"2018","unstructured":"Chen T.; Zhang Y.; Shang Y.; Gu X.; Zhu Y.; Zhu L.; NBD-BPEA regulates Zn2+- or Cu2+-induced A&#x3B2;40 aggregation and cytotoxicity. Food Chem Toxicol 2018,119,260-267","journal-title":"Food Chem Toxicol"},{"key":"ref=60","doi-asserted-by":"publisher","first-page":"21826","DOI":"10.1038\/srep21826","volume":"6","author":"Su T.","year":"2016","unstructured":"Su T.; Zhang T.; Xie S.; Discovery of novel PDE9 inhibitors capable of inhibiting A&#x3B2; aggregation as potential candidates for the treatment of Alzheimer\u2019s disease. Sci Rep 2016,6(1),21826","journal-title":"Sci Rep"},{"key":"ref=61","doi-asserted-by":"publisher","first-page":"4823","DOI":"10.1016\/j.bmc.2018.08.019","volume":"26","author":"Mart&#xED;nez A.","year":"2018","unstructured":"Mart&#xED;nez A.; Zahran M.; Gomez M.; Novel multi-target compounds in the quest for new chemotherapies against Alzheimer\u2019s disease: An experimental and theoretical study. Bioorg Med Chem 2018,26(17),4823-4840","journal-title":"Bioorg Med Chem"},{"key":"ref=62","doi-asserted-by":"publisher","first-page":"5917","DOI":"10.1016\/j.bmc.2017.08.048","volume":"25","author":"Yang H.L.","year":"2017","unstructured":"Yang H.L.; Cai P.; Liu Q.H.; Design, synthesis, and evaluation of salicyladimine derivatives as multitarget-directed ligands against Alzheimer\u2019s disease. Bioorg Med Chem 2017,25(21),5917-5928","journal-title":"Bioorg Med Chem"},{"key":"ref=63","doi-asserted-by":"publisher","first-page":"3657","DOI":"10.1016\/j.bmc.2016.06.012","volume":"24","author":"Mart&#xED;nez A.","year":"2016","unstructured":"Mart&#xED;nez A.; Alcendor R.; Rahman T.; Podgorny M.; Sanogo I.; Mccurdy R.; Ionophoric polyphenols selectively bind Cu2+, display potent antioxidant and anti-amyloidogenic properties, and are non-toxic toward Tetrahymena thermophila. Bioorg Med Chem 2016,24(16),3657-3670","journal-title":"Bioorg Med Chem"},{"key":"ref=64","doi-asserted-by":"publisher","first-page":"3610","DOI":"10.3390\/molecules25163610","volume":"25","author":"Bowroju S.K.","year":"2020","unstructured":"Bowroju S.K.; Mainali N.; Ayyadevara S.; Design and synthesis of novel hybrid 8-hydroxy quinoline-indole derivatives as inhibitors of A&#x3B2; self-aggregation and metal chelation-induced A&#x3B2; aggregation. Molecules 2020,25(16),3610","journal-title":"Molecules"},{"key":"ref=65","doi-asserted-by":"publisher","first-page":"113821","DOI":"10.1016\/j.ejmech.2021.113821","volume":"225","author":"Wang X.X.","year":"2021","unstructured":"Wang X.X.; Xie F.; Jia C.C.; Synthesis and biological evaluation of selective histone deacetylase 6 inhibitors as multifunctional agents against Alzheimer\u2019s disease. Eur J Med Chem 2021,225,113821","journal-title":"Eur J Med Chem"},{"key":"ref=66","doi-asserted-by":"publisher","first-page":"4717","DOI":"10.1016\/j.bmc.2014.07.009","volume":"22","author":"Li Y.","year":"2014","unstructured":"Li Y.; Peng P.; Tang L.; Hu Y.; Hu Y.; Sheng R.; Design, synthesis and evaluation of rivastigmine and curcumin hybrids as site-activated multitarget-directed ligands for Alzheimer\u2019s disease therapy. Bioorg Med Chem 2014,22(17),4717-4725","journal-title":"Bioorg Med Chem"},{"key":"ref=67","doi-asserted-by":"publisher","first-page":"3161","DOI":"10.4155\/fmc-2019-0106","volume":"11","author":"Swetha R.","year":"2019","unstructured":"Swetha R.; Kumar D.; Gupta S.K.; Multifunctional hybrid sulfonamides as novel therapeutic agents for Alzheimer\u2019s disease. Future Med Chem 2019,11(24),3161-3178","journal-title":"Future Med Chem"},{"key":"ref=68","doi-asserted-by":"publisher","first-page":"6089","DOI":"10.1016\/j.bmc.2014.08.035","volume":"22","author":"Lan J.S.","year":"2014","unstructured":"Lan J.S.; Xie S.S.; Li S.Y.; Pan L.F.; Wang X.B.; Kong L.Y.; Design, synthesis and evaluation of novel tacrine-(&#x3B2;-carboline) hybrids as multifunctional agents for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem 2014,22(21),6089-6104","journal-title":"Bioorg Med Chem"},{"key":"ref=69","doi-asserted-by":"publisher","first-page":"111916","DOI":"10.1016\/j.ejmech.2019.111916","volume":"187","author":"Wichur T","year":"2020","unstructured":"Wichur T; Wi\u0119ckowska A, Wi\u0119ckowski K, et al. 1-Benzylpyrrolidine-3-amine-based BuChE inhibitors with anti-aggregating, antioxidant and metal-chelating properties as multifunctional agents against Alzheimer\u2019s disease. Eur J Med Chem 2020,187,111916","journal-title":"Eur J Med Chem"},{"key":"ref=70","doi-asserted-by":"publisher","first-page":"103524","DOI":"10.1016\/j.bioorg.2019.103524","volume":"95","author":"Mishra C.B.","year":"2020","unstructured":"Mishra C.B.; Gusain S.; Shalini S.; Development of novel carbazole derivatives with effective multifunctional action against Alzheimer\u2019s diseases: Design, synthesis, in silico, in vitro and in vivo investigation. Bioorg Chem 2020,95,103524","journal-title":"Bioorg Chem"},{"key":"ref=71","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.bmcl.2014.12.084","volume":"25","author":"Digiacomo M.","year":"2015","unstructured":"Digiacomo M.; Chen Z.; Wang S.; Synthesis and pharmacological evaluation of multifunctional tacrine derivatives against several disease pathways of AD. Bioorg Med Chem Lett 2015,25(4),807-810","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=72","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1016\/j.ejmech.2017.10.006","volume":"141","author":"Nesi G.","year":"2017","unstructured":"Nesi G.; Chen Q.; Sestito S.; Nature-based molecules combined with rivastigmine: A symbiotic approach for the synthesis of new agents against Alzheimer\u2019s disease. Eur J Med Chem 2017,141,232-239","journal-title":"Eur J Med Chem"},{"key":"ref=73","doi-asserted-by":"publisher","first-page":"6389","DOI":"10.1016\/j.bmc.2015.08.024","volume":"23","author":"Manral A.","year":"2015","unstructured":"Manral A.; Saini V.; Meena P.; Tiwari M.; Multifunctional novel Diallyl disulfide (DADS) derivatives with &#x3B2;-amyloid-reducing, cholinergic, antioxidant and metal chelating properties for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem 2015,23(19),6389-6403","journal-title":"Bioorg Med Chem"},{"key":"ref=74","doi-asserted-by":"publisher","first-page":"4324","DOI":"10.1016\/j.bmc.2016.07.025","volume":"24","author":"Wang J.","year":"2016","unstructured":"Wang J.; Wang Z.M.; Li X.M.; Synthesis and evaluation of multi-target-directed ligands for the treatment of Alzheimer\u2019s disease based on the fusion of donepezil and melatonin. Bioorg Med Chem 2016,24(18),4324-4338","journal-title":"Bioorg Med Chem"},{"key":"ref=75","doi-asserted-by":"publisher","first-page":"600","DOI":"10.1016\/j.ejmech.2018.04.058","volume":"152","author":"Jalili-Baleh L","year":"2018","unstructured":"Jalili-Baleh L; Forootanfar H; K&#xFC;&#xE7;&#xFC;kk\u0131l\u0131n&#xE7; TT, et al. Design, synthesis and evaluation of novel multi-target-directed ligands for treatment of Alzheimer\u2019s disease based on coumarin and lipoic acid scaffolds. Eur J Med Chem 2018,152,600-614","journal-title":"Eur J Med Chem"},{"key":"ref=76","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/j.jinorgbio.2016.05.001","volume":"161","author":"Hamulakova S.","year":"2016","unstructured":"Hamulakova S.; Poprac P.; Jomova K.; Targeting copper(II)-induced oxidative stress and the acetylcholinesterase system in Alzheimer\u2019s disease using multifunctional tacrine-coumarin hybrid molecules. J Inorg Biochem 2016,161,52-62","journal-title":"J Inorg Biochem"},{"key":"ref=77","doi-asserted-by":"publisher","first-page":"103977","DOI":"10.1016\/j.bioorg.2020.103977","volume":"101","author":"Patel D.V.","year":"2020","unstructured":"Patel D.V.; Patel N.R.; Kanhed A.M.; Novel carbazole-stilbene hybrids as multifunctional anti-Alzheimer agents. Bioorg Chem 2020,101,103977","journal-title":"Bioorg Chem"},{"key":"ref=78","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/j.1471-4159.2006.04258.x","volume":"100","author":"Avramovich-Tirosh Y.","year":"2007","unstructured":"Avramovich-Tirosh Y.; Amit T.; Bar-Am O.; Zheng H.; Fridkin M.; Youdim M.B.H.; Therapeutic targets and potential of the novel brain- permeable multifunctional iron chelator?monoamine oxidase inhibitor drug, M-30, for the treatment of Alzheimer\u2019s disease. J Neurochem 2007,100(2),490-502","journal-title":"J Neurochem"},{"key":"ref=79","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1111\/j.1471-4159.2005.03340.x","volume":"95","author":"Zheng H.","year":"2005","unstructured":"Zheng H.; Gal S.; Weiner L.M.; Novel multifunctional neuroprotective iron chelator-monoamine oxidase inhibitor drugs for neurodegenerative diseases: In vitro studies on antioxidant activity, prevention of lipid peroxide formation and monoamine oxidase inhibition. J Neurochem 2005,95(1),68-78","journal-title":"J Neurochem"},{"key":"ref=80","doi-asserted-by":"publisher","first-page":"860","DOI":"10.1089\/ars.2011.4279","volume":"17","author":"Kupershmidt L.","year":"2012","unstructured":"Kupershmidt L.; Amit T.; Bar-Am O.; Youdim M.B.H.; Weinreb O.; The novel multi-target iron chelating-radical scavenging compound M30 possesses beneficial effects on major hallmarks of Alzheimer\u2019s disease. Antioxid Redox Signal 2012,17(6),860-877","journal-title":"Antioxid Redox Signal"},{"key":"ref=81","doi-asserted-by":"publisher","first-page":"2886","DOI":"10.1016\/j.bbagen.2014.05.005","volume":"1840","author":"Liu J.","year":"2014","unstructured":"Liu J.; Qiu J.; Wang M.; Synthesis and characterization of 1H-phenanthro[9,10-d]imidazole derivatives as multifunctional agents for treatment of Alzheimer\u2019s disease. Biochim Biophys Acta, Gen Subj 2014,1840(9),2886-2903","journal-title":"Biochim Biophys Acta, Gen Subj"},{"key":"ref=82","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1016\/j.bmc.2015.01.042","volume":"23","author":"Liu Q.","year":"2015","unstructured":"Liu Q.; Qiang X.; Li Y.; Design, synthesis and evaluation of chromone-2-carboxamido-alkylbenzylamines as multifunctional agents for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem 2015,23(5),911-923","journal-title":"Bioorg Med Chem"},{"key":"ref=83","doi-asserted-by":"publisher","first-page":"103477","DOI":"10.1016\/j.bioorg.2019.103477","volume":"94","author":"Tian C.","year":"2020","unstructured":"Tian C.; Qiang X.; Song Q.; Flurbiprofen-chalcone hybrid mannich base derivatives as balanced multifunctional agents against Alzheimer\u2019s disease: Design, synthesis and biological evaluation. Bioorg Chem 2020,94,103477","journal-title":"Bioorg Chem"},{"key":"ref=84","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1016\/j.ejmech.2018.02.023","volume":"148","author":"Hiremathad A.","year":"2018","unstructured":"Hiremathad A.; Keri R.S.; Esteves A.R.; Cardoso S.M.; Chaves S.; Santos M.A.; Novel tacrine-hydroxyphenylbenzimidazole hybrids as potential multitarget drug candidates for Alzheimer\u2019s disease. Eur J Med Chem 2018,148,255-267","journal-title":"Eur J Med Chem"},{"key":"ref=85","doi-asserted-by":"publisher","first-page":"784","DOI":"10.1016\/j.ejmech.2016.09.052","volume":"125","author":"Chen Z.","year":"2017","unstructured":"Chen Z.; Digiacomo M.; Tu Y.; Discovery of novel rivastigmine-hydroxycinnamic acid hybrids as multi-targeted agents for Alzheimer\u2019s disease. Eur J Med Chem 2017,125,784-792","journal-title":"Eur J Med Chem"},{"key":"ref=86","doi-asserted-by":"publisher","first-page":"10462","DOI":"10.1021\/jacs.1c05470","volume":"143","author":"Sun L.","year":"2021","unstructured":"Sun L.; Cho H.J.; Sen S.; Amphiphilic distyrylbenzene derivatives as potential therapeutic and imaging agents for soluble and insoluble amyloid &#x3B2; aggregates in Alzheimer\u2019s disease. J Am Chem Soc 2021,143(27),10462-10476","journal-title":"J Am Chem Soc"},{"key":"ref=87","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1021\/acschemneuro.0c00114","volume":"11","author":"Cho H.J.","year":"2020","unstructured":"Cho H.J.; Sharma A.K.; Zhang Y.; Gross M.L.; Mirica L.M.; A multifunctional chemical agent as an attenuator of amyloid burden and neuroinflammation in Alzheimer\u2019s disease. ACS Chem Neurosci 2020,11(10),1471-1481","journal-title":"ACS Chem Neurosci"},{"key":"ref=88","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.ejmech.2019.02.001","volume":"167","author":"Shi X.L.","year":"2019","unstructured":"Shi X.L.; Wu J.D.; Liu P.; Liu Z.P.; Synthesis and evaluation of novel GSK-3&#x3B2; inhibitors as multifunctional agents against Alzheimer\u2019s disease. Eur J Med Chem 2019,167,211-225","journal-title":"Eur J Med Chem"},{"key":"ref=89","doi-asserted-by":"publisher","first-page":"499","DOI":"10.1016\/0891-5849(92)90144-6","volume":"13","author":"Morel I.","year":"1992","unstructured":"Morel I.; Cillard J.; Lescoat G.; Antioxidant and free radical scavenging activities of the iron chelators pyoverdin and hydroxypyrid-4-ones in iron-loaded hepatocyte cultures: Comparison of their mechanism of protection with that of desferrioxamine. Free Radic Biol Med 1992,13(5),499-508","journal-title":"Free Radic Biol Med"},{"key":"ref=90","doi-asserted-by":"publisher","first-page":"2466","DOI":"10.1111\/j.1471-4159.2008.05332.x","volume":"105","author":"Molina-Holgado F.","year":"2008","unstructured":"Molina-Holgado F.; Gaeta A.; Francis P.T.; Williams R.J.; Hider R.C.; Neuroprotective actions of deferiprone in cultured cortical neurones and SHSY-5Y cells. J Neurochem 2008,105(6),2466-2476","journal-title":"J Neurochem"},{"key":"ref=91","doi-asserted-by":"publisher","first-page":"167","DOI":"10.3233\/JAD-2012-111346","volume":"30","author":"Prasanthi J.R.P.","year":"2012","unstructured":"Prasanthi J.R.P.; Schrag M.; Dasari B.; Deferiprone reduces amyloid-&#x3B2; and tau phosphorylation levels but not reactive oxygen species generation in hippocampus of rabbits fed a cholesterol-enriched diet. J Alzheimers Dis 2012,30(1),167-182","journal-title":"J Alzheimers Dis"},{"key":"ref=92","doi-asserted-by":"publisher","first-page":"218","DOI":"10.3389\/fnagi.2014.00218","volume":"6","author":"Rege S.D.","year":"2014","unstructured":"Rege S.D.; Geetha T.; Griffin G.D.; Broderick T.L.; Babu J.R.; Neuroprotective effects of resveratrol in Alzheimer disease pathology. Front Aging Neurosci 2014,6,218","journal-title":"Front Aging Neurosci"},{"key":"ref=93","doi-asserted-by":"publisher","first-page":"5843","DOI":"10.1021\/jm400567s","volume":"56","author":"Lu C.","year":"2013","unstructured":"Lu C.; Guo Y.; Yan J.; Design, synthesis, and evaluation of multitarget-directed resveratrol derivatives for the treatment of Alzheimer\u2019s disease. J Med Chem 2013,56(14),5843-5859","journal-title":"J Med Chem"},{"key":"ref=94","doi-asserted-by":"publisher","first-page":"191","DOI":"10.3233\/JAD-131031","volume":"40","author":"Solberg N.O.","year":"2014","unstructured":"Solberg N.O.; Chamberlin R.; Vigil J.R.; Optical and SPION-enhanced MR imaging shows that trans-stilbene inhibitors of NF-&#x3BA;B concomitantly lower Alzheimer\u2019s disease plaque formation and microglial activation in A&#x3B2;PP\/PS-1 transgenic mouse brain. J Alzheimers Dis 2014,40(1),191-212","journal-title":"J Alzheimers Dis"},{"key":"ref=95","doi-asserted-by":"publisher","first-page":"736","DOI":"10.1080\/14786419.2018.1496429","volume":"34","author":"Cao Y.","year":"2020","unstructured":"Cao Y.; Xu W.; Huang Y.; Zeng X.; Licochalcone B, a chalcone derivative from Glycyrrhiza inflata, as a multifunctional agent for the treatment of Alzheimer\u2019s disease. Nat Prod Res 2020,34(5),736-739","journal-title":"Nat Prod Res"},{"key":"ref=96","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.cbi.2008.05.003","volume":"174","author":"Ak T.","year":"2008","unstructured":"Ak T.; G&#xFC;l&#xE7;in \u0130 Antioxidant and radical scavenging properties of curcumin. Chem Biol Interact 2008,174(1),27-37","journal-title":"Chem Biol Interact"},{"key":"ref=97","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1002\/biof.1504","volume":"45","author":"Shakeri A.","year":"2019","unstructured":"Shakeri A.; Panahi Y.; Johnston T.P.; Sahebkar A.; Biological properties of metal complexes of curcumin. Biofactors 2019,45(3),304-317","journal-title":"Biofactors"},{"key":"ref=98","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1111\/j.1755-5949.2010.00147.x","volume":"16","author":"Hamaguchi T.","year":"2010","unstructured":"Hamaguchi T.; Ono K.; Yamada M.; Review: Curcumin and Alzheimer\u2019s disease. CNS Neurosci Ther 2010,16(5),285-297","journal-title":"CNS Neurosci Ther"},{"key":"ref=99","doi-asserted-by":"publisher","first-page":"348","DOI":"10.1016\/j.ejmech.2015.02.063","volume":"94","author":"Sang Z.","year":"2015","unstructured":"Sang Z.; Qiang X.; Li Y.; Design, synthesis and evaluation of scutellarein-O-alkylamines as multifunctional agents for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 2015,94,348-366","journal-title":"Eur J Med Chem"},{"key":"ref=100","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.3233\/JAD-170188","volume":"58","author":"Tang M.","year":"2017","unstructured":"Tang M.; Taghibiglou C.; The mechanisms of action of curcumin in Alzheimer\u2019s disease. J Alzheimers Dis 2017,58(4),1003-1016","journal-title":"J Alzheimers Dis"},{"key":"ref=101","doi-asserted-by":"publisher","first-page":"3507","DOI":"10.1007\/s00253-020-10461-x","volume":"104","author":"Sun Z.Z.","year":"2020","unstructured":"Sun Z.Z.; Li X.Y.; Wang S.; Shen L.; Ji H.F.; Bidirectional interactions between curcumin and gut microbiota in transgenic mice with Alzheimer\u2019s disease. Appl Microbiol Biotechnol 2020,104(8),3507-3515","journal-title":"Appl Microbiol Biotechnol"},{"key":"ref=102","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.ejmech.2019.07.021","volume":"180","author":"Sang Z.","year":"2019","unstructured":"Sang Z.; Wang K.; Zhang P.; Shi J.; Liu W.; Tan Z.; Design, synthesis, in-silico and biological evaluation of novel chalcone derivatives as multi-function agents for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 2019,180,238-252","journal-title":"Eur J Med Chem"},{"key":"ref=103","doi-asserted-by":"publisher","first-page":"726","DOI":"10.1016\/j.ejmech.2019.06.026","volume":"178","author":"Sang Z.","year":"2019","unstructured":"Sang Z.; Wang K.; Shi J.; Liu W.; Tan Z.; Design, synthesis, in-silico and biological evaluation of novel chalcone-O-carbamate derivatives as multifunctional agents for the treatment of Alzheimer\u2019s disease. Eur J Med Chem 2019,178,726-739","journal-title":"Eur J Med Chem"},{"key":"ref=104","doi-asserted-by":"publisher","first-page":"3386","DOI":"10.1021\/acschemneuro.9b00232","volume":"10","author":"Nam G.","year":"2019","unstructured":"Nam G.; Ji Y.; Lee H.J.; Orobol: An isoflavone exhibiting regulatory multifunctionality against four pathological features of Alzheimer\u2019s disease. ACS Chem Neurosci 2019,10(8),3386-3390","journal-title":"ACS Chem Neurosci"},{"key":"ref=105","doi-asserted-by":"publisher","first-page":"NP11","DOI":"10.1177\/2156587215610032","volume":"21","author":"Ademosun A.O.","year":"2016","unstructured":"Ademosun A.O.; Oboh G.; Bello F.; Ayeni P.O.; Antioxidative properties and effect of quercetin and its glycosylated form (rutin) on acetylcholinesterase and butyrylcholinesterase activities. J Evid Based Complementary Altern Med 2016,21(4),NP11-NP17","journal-title":"J Evid Based Complementary Altern Med"},{"key":"ref=106","doi-asserted-by":"publisher","first-page":"893","DOI":"10.1007\/s12640-019-00142-7","volume":"37","author":"da Silva W.M.B.","year":"2020","unstructured":"da Silva W.M.B.; de Oliveira P.S.; Alves D.R.; Synthesis of quercetin-metal complexes, in vitro and in silico anticholinesterase and antioxidant evaluation, and in vivo toxicological and anxiolitic activities. Neurotox Res 2020,37(4),893-903","journal-title":"Neurotox Res"},{"key":"ref=107","doi-asserted-by":"publisher","first-page":"59","DOI":"10.3390\/biom10010059","volume":"10","author":"Khan H.","year":"2019","unstructured":"Khan H.; Ullah H.; Aschner M.; Cheang W.S.; Akkol E.K.; Neuroprotective effects of quercetin in Alzheimer\u2019s disease. Biomolecules 2019,10(1),59","journal-title":"Biomolecules"},{"key":"ref=108","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1007\/s13765-016-0217-0","volume":"59","author":"Kim J.H.","year":"2016","unstructured":"Kim J.H.; Lee J.; Lee S.; Cho E.J.; Quercetin and quercetin-3-&#x3B2;-d-glucoside improve cognitive and memory function in Alzheimer\u2019s disease mouse. Applied Biol Chem 2016,59(5),721-728","journal-title":"Applied Biol Chem"},{"key":"ref=109","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1016\/j.etp.2012.05.003","volume":"65","author":"Guo L.L.","year":"2013","unstructured":"Guo L.L.; Guan Z.Z.; Huang Y.; Wang Y.L.; Shi J.S.; The neurotoxicity of &#x3B2;-amyloid peptide toward rat brain is associated with enhanced oxidative stress, inflammation and apoptosis, all of which can be attenuated by scutellarin. Exp Toxicol Pathol 2013,65(5),579-584","journal-title":"Exp Toxicol Pathol"},{"key":"ref=110","doi-asserted-by":"publisher","first-page":"2959","DOI":"10.1016\/j.lfs.2003.09.074","volume":"74","author":"Hong H.","year":"2004","unstructured":"Hong H.; Liu G.Q.; Protection against hydrogen peroxide-induced cytotoxicity in PC12 cells by scutellarin. Life Sci 2004,74(24),2959-2973","journal-title":"Life Sci"},{"key":"ref=111","doi-asserted-by":"publisher","first-page":"3225","DOI":"10.3390\/molecules23123225","volume":"23","author":"Liu Q.","year":"2018","unstructured":"Liu Q.; Li X.; Ouyang X.; Chen D.; Dual effect of glucuronidation of a pyrogallol-type phytophenol antioxidant: A comparison between scutellarein and scutellarin. Molecules 2018,23(12),3225","journal-title":"Molecules"},{"key":"ref=112","doi-asserted-by":"publisher","first-page":"869","DOI":"10.3390\/molecules23040869","volume":"23","author":"Zeng Y.Q.","year":"2018","unstructured":"Zeng Y.Q.; Cui Y.B.; Gu J.H.; Liang C.; Zhou X.F.; Scutellarin mitigates A&#x3B2;-induced neurotoxicity and improves behavior impairments in AD mice. Molecules 2018,23(4),869","journal-title":"Molecules"},{"key":"ref=113","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1002\/mnfr.200500156","volume":"50","author":"Mandel S.","year":"2006","unstructured":"Mandel S.; Amit T.; Reznichenko L.; Weinreb O.; Youdim M.B.H.; Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders. Mol Nutr Food Res 2006,50(2),229-234","journal-title":"Mol Nutr Food Res"},{"key":"ref=114","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1159\/000085385","volume":"14","author":"Mandel S.A.","year":"2005","unstructured":"Mandel S.A.; Avramovich-Tirosh Y.; Reznichenko L.; Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway. Neurosignals 2005,14(1-2),46-60","journal-title":"Neurosignals"},{"key":"ref=115","doi-asserted-by":"publisher","first-page":"173","DOI":"10.3390\/ijms19010173","volume":"19","author":"Kim E.","year":"2018","unstructured":"Kim E.; Hwang K.; Lee J.; Skin protective effect of epigallocatechin gallate. Int J Mol Sci 2018,19(1),173","journal-title":"Int J Mol Sci"},{"key":"ref=116","doi-asserted-by":"publisher","first-page":"927","DOI":"10.2174\/1389450118666170328122527","volume":"19","author":"Syarifah-Noratiqah S.B.","year":"2018","unstructured":"Syarifah-Noratiqah S.B.; Naina-Mohamed I.; Zulfarina M.S.; Qodriyah H.M.S.; Natural polyphenols in the treatment of Alzheimer\u2019s disease. Curr Drug Targets 2018,19(8),927-937","journal-title":"Curr Drug Targets"},{"key":"ref=117","doi-asserted-by":"publisher","first-page":"1901","DOI":"10.1021\/acschemneuro.7b00071","volume":"8","author":"Kantham S.","year":"2017","unstructured":"Kantham S.; Chan S.; McColl G.; Effect of the biphenyl neolignan honokiol on A&#x3B2;42-induced toxicity in caenorhabditis elegans, A&#x3B2;42 fibrillation, cholinesterase activity, DPPH radicals, and iron(II) chelation. ACS Chem Neurosci 2017,8(9),1901-1912","journal-title":"ACS Chem Neurosci"},{"key":"ref=118","doi-asserted-by":"publisher","first-page":"101005","DOI":"10.1016\/j.isci.2020.101005","volume":"23","author":"Rajasekhar K.","year":"2020","unstructured":"Rajasekhar K.; Samanta S.; Bagoband V.; Murugan N.A.; Govindaraju T.; Antioxidant berberine-derivative inhibits multifaceted amyloid toxicity. iScience 2020,23(4),101005","journal-title":"iScience"},{"key":"ref=119","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1007\/s11030-013-9452-z","volume":"17","author":"Cao Y.Y.","year":"2013","unstructured":"Cao Y.Y.; Wang L.; Ge H.; Salvianolic acid A, a polyphenolic derivative from Salvia miltiorrhiza bunge, as a multifunctional agent for the treatment of Alzheimer\u2019s disease. Mol Divers 2013,17(3),515-524","journal-title":"Mol Divers"},{"key":"ref=120","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1016\/j.jchromb.2009.02.013","volume":"877","author":"Sun Y.","year":"2009","unstructured":"Sun Y.; Zhu H.; Wang J.; Liu Z.; Bi J.; Isolation and purification of salvianolic acid A and salvianolic acid B from Salvia miltiorrhiza by high-speed counter-current chromatography and comparison of their antioxidant activity. J Chromatogr B Analyt Technol Biomed Life Sci 2009,877(8-9),733-737","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"ref=121","doi-asserted-by":"publisher","first-page":"105976","DOI":"10.1016\/j.ejps.2021.105976","volume":"166","author":"Liu C.","year":"2021","unstructured":"Liu C.; Kou X.; Wang X.; Wu J.; Yang A.; Shen R.; Novel chrysin derivatives as hidden multifunctional agents for anti-Alzheimer\u2019s disease: Design, synthesis and in vitro evaluation. Eur J Pharm Sci 2021,166,105976","journal-title":"Eur J Pharm Sci"},{"key":"ref=122","doi-asserted-by":"publisher","first-page":"128316","DOI":"10.1016\/j.bmcl.2021.128316","volume":"49","author":"Wu J.","year":"2021","unstructured":"Wu J.; Kou X.; Ju H.; Zhang H.; Yang A.; Shen R.; Design, synthesis and biological evaluation of naringenin carbamate derivatives as potential multifunctional agents for the treatment of Alzheimer\u2019s disease. Bioorg Med Chem Lett 2021,49,128316","journal-title":"Bioorg Med Chem Lett"},{"key":"ref=123","doi-asserted-by":"publisher","first-page":"130459","DOI":"10.1016\/j.molstruc.2021.130459","volume":"1239","author":"Kou X.","year":"2021","unstructured":"Kou X.; Liu J.; Chen Y.; Yang A.; Shen R.; Emodin derivatives with multi-factor anti-AD activities: AChE inhibitor, anti-oxidant and metal chelator. J Mol Struct 2021,1239,130459","journal-title":"J Mol Struct"},{"key":"ref=124","doi-asserted-by":"publisher","first-page":"120587","DOI":"10.1016\/j.saa.2021.120587","volume":"267","author":"Kou X.","year":"2022","unstructured":"Kou X.; Li X.; Hu C.; Multifunctional fluorescence sensor as a potential theranostic agent against Alzheimer\u2019s disease. Spectrochim Acta A Mol Biomol Spectrosc 2022,267(Pt 2),120587","journal-title":"Spectrochim Acta A Mol Biomol Spectrosc"}],"container-title":["Current Drug Targets"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450123666220926143920","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/209154\/article","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.eurekaselect.com\/article\/download?doi=10.2174\/1389450123666220926143920","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,3,30]],"date-time":"2023-03-30T04:41:40Z","timestamp":1680151300000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.eurekaselect.com\/209154\/article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,2]]},"references-count":124,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["LiveAll1"],"URL":"https:\/\/doi.org\/10.2174\/1389450123666220926143920","relation":{},"ISSN":["1389-4501"],"issn-type":[{"value":"1389-4501","type":"print"}],"subject":[],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Peer Reviewed","order":0,"name":"review_status","label":"Review Status","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Single blind","order":1,"name":"review_process","label":"Review Process","group":{"name":"peer_review_details","label":"Peer Review Details"}},{"value":"Checked with iThenticate","order":0,"name":"screening_status","label":"Screening Status","group":{"name":"plagiarism_screening","label":"Plagiarism Screening"}},{"value":"2022-03-25","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-05-23","order":1,"name":"revised","label":"Revised","group":{"name":"publication_history","label":"Publication History"}},{"value":"2022-08-01","order":2,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-02-16","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}